Gemcitabine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064348
  • May 2021
  • Pharmaceuticals
  • 124 Pages
The global Gemcitabine market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Gemcitabine market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Gemcitabine market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Gemcitabine market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Teva Pharmaceutical Industries Ltd., Sanofi, Biocon., Dr. Reddy\'s Laboratories, Sun Pharmaceutical Industries Ltd., Mylan N.V., GlaxoSmithKline plc., AstraZeneca plc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Gemcitabine market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Gemcitabine market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Gemcitabine market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Gemcitabine market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Gemcitabine Market:
The Gemcitabine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Teva Pharmaceutical Industries Ltd., Sanofi, Biocon., Dr. Reddy\'s Laboratories, Sun Pharmaceutical Industries Ltd., Mylan N.V., GlaxoSmithKline plc., AstraZeneca plc.

Gemcitabine Market Segment Analysis:
By Application
Pancreas Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Soft-Tissue Sarcoma
Metastatic Breast Cancer
Ovarian Cancer
End-User
Hospitals
Cancer Centers
Others
Distribution Channel
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies

Geographic Coverage for Gemcitabine Market:
The market research report on global Gemcitabine market offers complete analysis across various regions across the world. The Gemcitabine market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Gemcitabine market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Gemcitabine Market Value and Forecast
  • US
  • Canada
Europe Gemcitabine Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Gemcitabine Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Gemcitabine Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Gemcitabine Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Gemcitabine market report:
  • The report provides key trends of the global Gemcitabine market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Gemcitabine industry
  • The report covers all the recent developments of the Gemcitabine market and helps to provide current industry updates
  • The report covers a detailed look over the global Gemcitabine Industry and provides with significant actionable insights
  • The Gemcitabine market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Gemcitabine market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Gemcitabine market
  • Comprehensive analysis of the Gemcitabine market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Gemcitabine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Gemcitabine market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Gemcitabine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Gemcitabine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Gemcitabine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Biocon.
  • Dr. Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • GlaxoSmithKline plc.
  • AstraZeneca plc.
  • Pancreas Cancer
  • Non-Small Cell Lung Cancer
  • Bladder Cancer
  • Soft-Tissue Sarcoma
  • Metastatic Breast Cancer
  • Ovarian Cancer
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Gemcitabine Market Snapshot
          2.1.1. Global Gemcitabine Market By Distribution Channel,2019
               2.1.1.1.Pancreas Cancer
               2.1.1.2.Non-Small Cell Lung Cancer
               2.1.1.3.Bladder Cancer
               2.1.1.4.Soft-Tissue Sarcoma
               2.1.1.5.Metastatic Breast Cancer
               2.1.1.6.Ovarian Cancer
          2.1.2. Global Gemcitabine Market By Distribution Channel,2019
               2.1.2.1.Online Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Hospital Pharmacies
          2.1.3. Global Gemcitabine Market By End-use,2019
          2.1.4. Global Gemcitabine Market By Geography,2019

3. Global Gemcitabine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     4.2. Global Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028

5. Global Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Gemcitabine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Gemcitabine Market Size (US$), By End-use, 2018 – 2028

7. Global Gemcitabine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Gemcitabine Market Analysis, 2018 – 2028 
          7.2.1. North America Gemcitabine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.3. North America Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Gemcitabine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Gemcitabine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Gemcitabine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.3. Europe Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Gemcitabine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Gemcitabine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Gemcitabine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.3. Asia Pacific Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Gemcitabine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Gemcitabine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Gemcitabine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.3. Latin America Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Gemcitabine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Gemcitabine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Gemcitabine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.3. MEA Gemcitabine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Gemcitabine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Gemcitabine Providers
        8.4.1 Teva Pharmaceutical Industries Ltd.
                8.4.1.1 Business Description
                8.4.1.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.1.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.1.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.1.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.2 Sanofi
                8.4.2.1 Business Description
                8.4.2.2 Sanofi Geographic Operations
                8.4.2.3 Sanofi Financial Information
                8.4.2.4 Sanofi Product Positions/Portfolio
                8.4.2.5 Sanofi Key Developments
        8.4.3 Biocon.
                8.4.3.1 Business Description
                8.4.3.2 Biocon. Geographic Operations
                8.4.3.3 Biocon. Financial Information
                8.4.3.4 Biocon. Product Positions/Portfolio
                8.4.3.5 Biocon. Key Developments
        8.4.4 Dr. Reddy's Laboratories
                8.4.4.1 Business Description
                8.4.4.2 Dr. Reddy's Laboratories Geographic Operations
                8.4.4.3 Dr. Reddy's Laboratories Financial Information
                8.4.4.4 Dr. Reddy's Laboratories Product Positions/Portfolio
                8.4.4.5 Dr. Reddy's Laboratories Key Developments
        8.4.5 Sun Pharmaceutical Industries Ltd.
                8.4.5.1 Business Description
                8.4.5.2 Sun Pharmaceutical Industries Ltd. Geographic Operations
                8.4.5.3 Sun Pharmaceutical Industries Ltd. Financial Information
                8.4.5.4 Sun Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.5.5 Sun Pharmaceutical Industries Ltd. Key Developments
        8.4.6 Mylan N.V.
                8.4.6.1 Business Description
                8.4.6.2 Mylan N.V. Geographic Operations
                8.4.6.3 Mylan N.V. Financial Information
                8.4.6.4 Mylan N.V. Product Positions/Portfolio
                8.4.6.5 Mylan N.V. Key Developments
        8.4.7 GlaxoSmithKline plc.
                8.4.7.1 Business Description
                8.4.7.2 GlaxoSmithKline plc. Geographic Operations
                8.4.7.3 GlaxoSmithKline plc. Financial Information
                8.4.7.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.7.5 GlaxoSmithKline plc. Key Developments
        8.4.8 AstraZeneca plc.
                8.4.8.1 Business Description
                8.4.8.2 AstraZeneca plc. Geographic Operations
                8.4.8.3 AstraZeneca plc. Financial Information
                8.4.8.4 AstraZeneca plc. Product Positions/Portfolio
                8.4.8.5 AstraZeneca plc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Gemcitabine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Gemcitabine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Gemcitabine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Gemcitabine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Gemcitabine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Gemcitabine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Gemcitabine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Gemcitabine: Market Segmentation 
FIG. 2 Global Gemcitabine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Gemcitabine Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 5 Global Gemcitabine Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Gemcitabine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Gemcitabine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Gemcitabine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Gemcitabine Providers, 2019
FIG. 11 Global Gemcitabine Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 12 Global Gemcitabine Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Gemcitabine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Gemcitabine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Gemcitabine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Gemcitabine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Gemcitabine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Gemcitabine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Gemcitabine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Gemcitabine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Gemcitabine Market Value, By Segment1, 2018 – 2028
TABLE  North America Gemcitabine Market Value, By Segment2, 2018 – 2028
TABLE  North America Gemcitabine Market Value, By Country, 2018 – 2028
TABLE  Europe Gemcitabine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Gemcitabine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Gemcitabine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Gemcitabine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Gemcitabine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Gemcitabine Market Value, By Country, 2018 – 2028
TABLE  Latin America Gemcitabine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Gemcitabine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Gemcitabine Market Value, By Country, 2018 – 2028
TABLE  MEA Gemcitabine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Gemcitabine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Gemcitabine Market Value, By Country, 2018 – 2028
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dr. Reddy's Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Gemcitabine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Gemcitabine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Gemcitabine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Gemcitabine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Gemcitabine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Gemcitabine Providers, 2016
FIG.  Global Gemcitabine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Non-Small Cell Lung Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Bladder Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Soft-Tissue Sarcoma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Metastatic Breast Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ovarian Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gemcitabine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospital Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Gemcitabine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Gemcitabine Market Value, 2018 – 2028, (US$ Mn)